These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1274972)

  • 1. Particulate matter assessment of a clinical investigation on filtration and infusion phlebitis.
    Schroeder HG; DeLuca PP
    Am J Hosp Pharm; 1976 Jun; 33(6):543-6. PubMed ID: 1274972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of inline filtration on postinfusion phlebitis.
    Maddox RR; John JF; Brown LL; Smith CE
    Clin Pharm; 1983; 2(1):58-61. PubMed ID: 6883931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inline filtration of intravenous infusions on the incidence of thrombophlebitis.
    Chamberland ME; Lyons RW; Brock SM
    Am J Hosp Pharm; 1977 Oct; 34(10):1068-70. PubMed ID: 920740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind study to investigate methods to prevent cephalothin-induced phlebitis.
    Maddox RR; Rush DR; Rapp RP; Foster TS; Mazella V; McKean HE
    Am J Hosp Pharm; 1977 Jan; 34(1):29-34. PubMed ID: 831472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filtration and infusion phlebitis: a double-blind prospective clinical study.
    DeLuca PP; Rapp RP; Bivins B; McKean HE; Griffen WO
    Am J Hosp Pharm; 1975 Oct; 32(10):1001-7. PubMed ID: 1103617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particulate matter in four reconstituted cephalosporin injections.
    Kilarski DJ; Visconti JA; Frank SG
    Am J Hosp Pharm; 1983 Apr; 40(4):619-23. PubMed ID: 6846372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind evaluation of 5-mum final filtration to reduce postinfusion phlebitis.
    Evans WE; Barker LF; Simone JV
    Am J Hosp Pharm; 1976 Nov; 33(11):1160-3. PubMed ID: 998633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of inline filtration on delivery of gentamicin at a slow infusion rate.
    Nazeravich DR; Otten NH
    Am J Hosp Pharm; 1983 Nov; 40(11):1961-4. PubMed ID: 6650527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of particle-induced coronary vasoconstriction during cardioplegic infusion: is it desirable to use a microfilter in the infusion line?
    Munsch C; Rosenfeldt F; Chang V; Newman M; Davis B
    J Thorac Cardiovasc Surg; 1991 Mar; 101(3):473-80. PubMed ID: 1999941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postinfusion phlebitis associated with a syringe system versus minibags.
    Rapp RP; Powers P; Tolbert V; Piecoro JJ; Record KE
    Clin Pharm; 1986 May; 5(5):408-11. PubMed ID: 3720211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microparticulate-induced phlebitis. Its prevention by in-line filtration.
    Falchuk KH; Peterson L; McNeil BJ
    N Engl J Med; 1985 Jan; 312(2):78-82. PubMed ID: 3880597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections.
    De NC; Alam AS; Kapoor JN
    Am J Hosp Pharm; 1986 Jun; 43(6):1486-8. PubMed ID: 3728484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of microbial contamination during extended intravenous therapy using inline filters.
    Rusmin S; Althauser MB; DeLuca PP
    Am J Hosp Pharm; 1975 Apr; 32(4):373-7. PubMed ID: 805533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of particulate contamination in crystalloid cardioplegic solutions: studies by scanning and transmission electron microscopy.
    Hellinger A; Piotrowski J; Konerding MA; Burchard WG; Doetsch N; Peitgen K; Erhard J; Reidemeister JC
    Thorac Cardiovasc Surg; 1997 Feb; 45(1):20-6. PubMed ID: 9089970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of 0.9% sodium chloride injection with and without heparin for maintaining indwelling intermittent injection sites.
    Epperson EL
    Clin Pharm; 1984; 3(6):626-9. PubMed ID: 6509875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of primary fluids and dilutional volumes on the delivery of cefazolin sodium by a membrane infusion device.
    Nahata MC; Durrell DE; Miller MA
    Am J Hosp Pharm; 1989 Nov; 46(11):2318-21. PubMed ID: 2589351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In line final filters for removing particles from amphotericin B infusions.
    Huber RC; Riffkin C
    Am J Hosp Pharm; 1975 Feb; 32(2):173-6. PubMed ID: 237416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of paraldehyde in 5% dextrose and 0.9% sodium chloride injections through polyvinyl chloride i.v. sets and burettes.
    Welty TE; Cloyd JC; Abdel-Monem MM
    Am J Hosp Pharm; 1988 Jan; 45(1):131-5. PubMed ID: 3348226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infusion phlebitis associated with a programmable syringe-pump system versus gravity-feed minibottles.
    Baptista RJ; Driscoll DF; Gallagher JA; O'Keefe E; Dumas GJ; Hammer SM; Pacella PP
    Clin Pharm; 1987 Apr; 6(4):314-8. PubMed ID: 3665384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.